NET PROFIT (x1000 DKK)
EMPLOYEES
Expres2ion Biotechnologies ApS
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
-25,331
|
-61,130
|
-84,649 |
| Total assets |
57,974
|
50,210
|
91,017 |
| Current assets |
53,120
|
45,138
|
89,369 |
| Current liabilities |
24,241
|
7,314
|
21,148 |
| Equity capital |
32,798
|
41,931
|
68,532 |
| - share capital |
531
|
531
|
531 |
| Employees (average) |
15
|
15
|
15 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
56.6%
|
83.5%
|
75.3% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
219.1%
|
617.1%
|
422.6% |
| Return on equity (ROE) |
-77.2%
|
-145.8%
|
-123.5% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.